Atellica IM BR CA 27.29 | REF 10995477

The Siemens Atellica IM BR CA 27.29 assay (REF 10995477) is an in vitro diagnostic reagent designed for use on the Atellica IM Analyzer. It provides quantitative measurement of the tumor-associated antigen BR 27.29 (CA 27.29) in human serum and plasma using Siemens' acridinium ester chemiluminescent immunoassay technology.

Key Features
Ready-to-use reagent pack configured for the Atellica IM Analyzer.
Chemiluminescent immunoassay (CLIA) technology using acridinium ester label chemistry.
Quantitative determination of BR 27.29 (CA 27.29) tumor marker.
Automated onboard loading, mixing, and inventory tracking via integrated RFID.
Designed for consolidated workflow on the Atellica Solution platform.
Standardized reagent handling to support consistent run-to-run performance.

Clinical Applications
Intended for laboratory measurement of the BR 27.29 (CA 27.29) antigen as part of a broader oncology immunoassay testing menu.
Supports serial monitoring workflows used by clinicians in the assessment of patients with previously diagnosed breast carcinoma.
Suitable for high-throughput core laboratories, hospital laboratories, and reference laboratories running the Atellica IM Analyzer.
Specific intended use, indications, and interpretive claims: refer to the current Siemens Instructions for Use (IFU).

Product Information
Brand: Siemens Healthineers
Product: Atellica IM BR CA 27.29
REF / UPN: 10995477
Category: Laboratory — Immunoassay Reagents
Platform: Atellica IM Analyzer (Atellica Solution)
Methodology: Chemiluminescent immunoassay (acridinium ester)
Analyte: BR 27.29 (CA 27.29)
Sample Types: Human serum and plasma (refer to IFU for validated tube types)
Tests per Kit: Not specified in the located sources
Calibration / Controls: Use assay-specific Atellica IM calibrators and quality control materials per IFU
Storage & Stability: Refer to current Siemens IFU for storage temperature, onboard stability, and expiration handling
Regulatory Status: Refer to local Siemens Healthineers documentation for region-specific registration status

REF / UPN10995477
Size
Buyer support

Frequently asked questions about Atellica IM BR CA 27.29 | REF 10995477

Practical answers for procurement teams reviewing this product page.

Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.

Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.

Related products are connected through structured catalog data such as brand, category, product family and country assignment.

No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.

Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.

Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.

Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.

The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.

Your request has been captured successfully.